Mutations In Vp0 And 2c Proteins Of Duck Hepatitis A Virus Type 3 Attenuate Viral Infection And Virulence
Xingjian Wen,Jinlong Guo,Di Sun,Mingshu Wang,Dian Cao,Anchun Cheng,Dekang Zhu,Mafeng Liu,Xinxin Zhao,Qiao Yang,Shun Chen,Renyong Jia,Ying Wu,Shaqiu Zhang,Sai Mao,Xumin Ou,Xiaoyue Chen,Yanling Yu,Ling Zhang,Yunya Liu,Bin Tian,Leichang Pan,Mujeeb Ur Rehman
DOI: https://doi.org/10.3390/vaccines7030111
2019-01-01
Vaccines
Abstract:Duck hepatitis A virus (DHAV) is prevalent worldwide and has caused significant economic losses. As the predominant serotype in China, DHAV-3 has become a major challenge to the local duck industry. Here the genetics and pathogenesis of a virulent DHAV-3 strain and its embryo-passaged strain were assessed. There were only two amino acid substitutions (Y164N in VP0 protein and L71I in 2C protein) introduced during the adaptation process. The pathogenicity of these strains was further evaluated in vivo. Clinical signs, gross pathology, and histopathological analysis showed that the embryo-passaged strain was attenuated. Meanwhile, the viral RNA loads were significantly lower in the liver tissues of the ducklings infected with the attenuated strain. As expected, infection with the virulent and attenuated strains led to the activation of different innate immune genes. We suspected that the loss of replication efficiency in ducklings was responsible for the attenuation phenotype of the embryo-passaged strain. In addition, different innate immune responses in the liver of ducklings were at least partly responsible for the differential infectivity phenotype. These findings provide new insights into the genetics and pathogenesis of DHAV-3, which may aid the development of new vaccines and the implementation of immunization strategies.